Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunic Inc
(NQ:
IMUX
)
1.270
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,418
Open
1.270
Bid (Size)
1.270 (47)
Ask (Size)
1.340 (25)
Prev. Close
1.270
Today's Range
1.270 - 1.270
52wk Range
0.9451 - 3.110
Shares Outstanding
26,249,439
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
--News Direct--
Via
News Direct
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
March 21, 2024
Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month,...
Via
TheNewswire.com
Performance
YTD
-12.41%
-12.41%
1 Month
-3.79%
-3.79%
3 Month
+6.72%
+6.72%
6 Month
+11.40%
+11.40%
1 Year
-22.56%
-22.56%
More News
Read More
Immunic And 2 Other Stocks Under $2 Insiders Are Buying
February 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Immunic's Earnings Outlook
February 21, 2024
Via
Benzinga
What's Going On With Immunic Stock?
January 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 05, 2024
Via
Benzinga
Immunic: Q3 Earnings Insights
November 14, 2023
Via
Benzinga
A Preview Of Immunic's Earnings
November 13, 2023
Via
Benzinga
Immunic "super excited" about latest PMS trial data
October 11, 2023
Via
News Direct
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 05, 2024
Via
InvestorPlace
Immunic CSO hails "great" progress with MS program
October 24, 2023
Via
News Direct
Immunic CSO hails "great" progress with MS program
October 24, 2023
Via
TheNewswire.com
Immunic "super excited" about latest PMS trial data
October 11, 2023
Via
TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
Via
News Direct
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 10, 2023
Via
Benzinga
Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate
October 10, 2023
Via
Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
October 10, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 10, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
October 09, 2023
Via
Benzinga
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
Via
News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
Via
TheNewswire.com
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Via
News Direct
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Via
TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
Via
TheNewswire.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.